LIGAND PHARMACEUTICALS INCORPORATED
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2011 | $911.0K | $906.0K | $5.0K | $452.0K |
| Mar 2012 | $-369.0K | $-388.0K | $19.0K | $709.0K |
| Mar 2013 | $2.1M | $2.0M | $37.0K | $1.1M |
| Mar 2014 | $2.6M | $2.6M | $6.0K | $2.1M |
| Mar 2015 | $7.6M | $7.6M | $10.0K | $2.9M |
| Mar 2016 | $13.1M | $12.9M | $238.0K | $4.1M |
| Mar 2017 | $19.2M | $19.1M | $87.0K | $6.0M |
| Mar 2018 | $60.8M | $60.8M | — | $4.6M |
| Mar 2019 | $45.3M | $45.3M | — | $5.3M |
| Mar 2020 | $16.9M | $16.9M | — | $5.7M |
| Mar 2021 | $10.8M | $7.4M | $3.4M | $8.4M |
| Mar 2022 | $52.0M | $47.1M | $4.9M | $9.0M |
| Mar 2023 | $33.9M | $31.5M | $2.4M | $5.9M |
| Mar 2024 | $18.7M | $18.6M | $105.0K | $7.3M |
| Mar 2025 | $-25.4M | $-25.7M | $214.0K | $7.8M |
| Mar 2026 | $48.7M | $48.5M | $228.0K | $10.6M |